1.0hollandbiohttps://www.hollandbio.nl/en/rich600338<blockquote class="wp-embedded-content" data-secret="gSm1bAmFgx"><a href="https://www.hollandbio.nl/en/event-en/bioequity-europe-2025/">Bio€quity Europe 2025</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.hollandbio.nl/en/event-en/bioequity-europe-2025/embed/#?secret=gSm1bAmFgx" width="600" height="338" title="“Bio€quity Europe 2025” — hollandbio" data-secret="gSm1bAmFgx" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://www.hollandbio.nl/wp-includes/js/wp-embed.min.js </script> Biotech just became more complicated. The hottest trend is the competitive sourcing of assets from Asia to launch newcos in the West. At the same time, geopolitics is creating pressures against globalization and the exchange of data and talent across borders. In its 25th year, Bio€quity Europe asks what’s next for European biotech. Can it […]https://www.hollandbio.nl/wp-content/uploads/2025/02/BEE25_1200x600.jpg1200600